期刊文献+

塞来昔布对人食管癌细胞株Eca-109增殖和凋亡的影响 被引量:2

Effects of Celecoxib on the Proliferation and Apoptosis of Human Esophageal Carcinoma Cell Line Eca-109
下载PDF
导出
摘要 目的体外研究选择性环氧化酶-2(COX-2)抑制剂塞来昔布(celecoxib)对人食管癌细胞株Eca-109增殖和凋亡的影响,并探讨其可能的作用机制。方法采用噻唑蓝(MTT)比色法、流式细胞仪(FCM)、吖啶橙染色结合荧光显微镜观察细胞形态等技术,研究塞来昔布对Eca-109细胞增殖的抑制和促进凋亡的影响。结果MTT比色法显示塞来昔布对人食管癌Eca-109细胞有较强的抑制作用,呈时间和浓度依赖性;FCM显示有凋亡峰出现,凋亡率在(15.89±0.87)%^(73.57±1.63)%;塞来昔布使G0/G1期细胞比例升高,S期和G2/M期比例下降,呈一定效应关系;荧光显微镜下可见典型的细胞凋亡形态学特征:细胞体积缩小、细胞核固缩,凋亡小体形成等。凋亡比例呈剂量和时间依赖。结论塞来昔布体外能够显著抑制Eca-109增殖,诱导凋亡,可能与诱导凋亡和阻止细胞周期进展有关。 Objeetive To determine the effect of Celecoxib on the proliferation and human esophageal carcinoma cell Line Eca - 109 and the probable mechanism involved. Methods Using Methabenz- thiazuron (MTY) assay, flow cytometry (FCM) , Acridine orange staining. The effects of celecoxib on the proliferation and apoptosis of Eca - 109 cells as well as its related mechanism were studied. Results The growth of Eca - 109 cells was inhibited apparently by celecoxib in a time and dose dependent manners. Sub - G1 peak was detected by FCM, and apoptotic rate of which was ( 15.89 ±0.87)% (73.57 ±1.63)%. The cell ratio of GO/ G1 phase increased, whereas the cell ratio of S and G2/M phases decreased after treatment, which was in a dose - dependent manner as well. The treated Eca - 109 cells exhibited some morphological features of apoptosis, including cell shrinkage, nuclear condensation, DNA fragmentation, and the formation of apoptosis bodies, the apoptotic index of which was in a time and dose dependent manners. Conclusions tosis of Human Esophageal Carcinoma Cell Line Eca cle progress of Eca - 109 ceils. Celecoxib inhibited proliferation and induced apop- - 109, which may be related to blocking the cell cy cle progress of Eca - 109 ceils.
出处 《锦州医学院学报》 2006年第6期32-35,共4页 Journal of Jinzhou Medical College
关键词 塞来昔布 选择性环氧化酶-2抑制剂 Eca-109细胞系 细胞凋亡 细胞增殖 celecoxib selective cyclooxygenase -2 inhibitor Eca - 109 cell line cell proliferation cell apoptosis
  • 相关文献

参考文献12

  • 1Akre K,Ekstrom AM,Signorello LB,et al.Aspirin and risk for gastric cancer:apopulation -based case -contro study in Sweden[J].Br J Cancer,2001,84 (7):965.
  • 2Jacoby RF,Seibert K,Cole CE,et al.The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposiss[J].Cancer Res,2000,60 (18):5040.
  • 3Cryer B.Second-generation cyclooxygenase-2-specific inhibitors[J].Clin Perspec Gastroenterol,2002,5 (1):122 -128.
  • 4Buccoliro AM,Caldarella A,Aragannini L,et al.Cyclooxygensse-2 in oligodenaroglioma:possible prognost -ic significance[J].Neuropathology,2004,24 (3):201 -207.
  • 5Tuettenberg J,Grobholz R,Kom T,et al.Continuous low-dose chemotherapy plus inhibiti on of Cyclooxygensse -2 as an antiangiogenic therapy of glioblastoma multiforme[J].Cancer Res Clin Oncol,2005,131 (1):31 -40.
  • 6Kardosh A,Blumenthal M,Wang WJ,et al.Differential effects of selective COX-2 inhibition on cell cycle regulation and proliferation of gliblastoma cell lines[J].Cancer Boil Ther,2004,3 (1):55-62.
  • 7Buskens CJ,Van Reesbp,Sivula A,et al.Progonostic significance of elevated cyclooxygenase-2 expression in patients with adenocarcinoma of the esophagus[J].Gastroenterology,2002,122 (7):1800-1807.
  • 8Uefuji K,Ichikara T,Shinomiya K,et al.Induction of apoptosis by JTE -522,a specific cyclooxygenase -2 inhibitor,in human gastric cancer cell lines[J].Anticancer Res,2000,20(6B):4279 -4284.
  • 9Thorsten JM,Karin S,Ronald S,et al.cyclooxygenase -2 (COX-2)-dependent and independent anticarci-nogenic effects of celecoxib in human colon carcinoma cells[J].Biochem Pharmacol,2004,67 (8):1469.
  • 10Hsu AL,Ching TT,Wang DS,et al.The cyclooxygenase -2 inhibitor celecoxib induces apoptosis by blocking akt activation in human prostate cancer cells independently of bcl-2[J].Biol Chem,2000,275 (15):11397

二级参考文献5

共引文献27

同被引文献30

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部